296 related articles for article (PubMed ID: 12214321)
1. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs.
Adebowale A; Du J; Liang Z; Leslie JL; Eddington ND
Biopharm Drug Dispos; 2002 Sep; 23(6):217-25. PubMed ID: 12214321
[TBL] [Abstract][Full Text] [Related]
2. The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse.
Du J; White N; Eddington ND
Biopharm Drug Dispos; 2004 Apr; 25(3):109-16. PubMed ID: 15083499
[TBL] [Abstract][Full Text] [Related]
3. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
5. Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat.
Aghazadeh-Habashi A; Ibrahim A; Carran J; Anastassiades T; Jamali F
J Pharm Pharm Sci; 2006; 9(3):359-64. PubMed ID: 17207418
[TBL] [Abstract][Full Text] [Related]
6. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
Laverty S; Sandy JD; Celeste C; Vachon P; Marier JF; Plaas AH
Arthritis Rheum; 2005 Jan; 52(1):181-91. PubMed ID: 15641100
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
8. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
9. Effects of glucosamine-chondroitin sulfate supplementation on serum fructosamine concentration in healthy dogs.
Lenox CE; Lunn KF
J Am Vet Med Assoc; 2010 Jan; 236(2):183-6. PubMed ID: 20074008
[TBL] [Abstract][Full Text] [Related]
10. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
Kuroha M; Shirai Y; Shimoda M
J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
[TBL] [Abstract][Full Text] [Related]
11. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.
Jackson CG; Plaas AH; Sandy JD; Hua C; Kim-Rolands S; Barnhill JG; Harris CL; Clegg DO
Osteoarthritis Cartilage; 2010 Mar; 18(3):297-302. PubMed ID: 19912983
[TBL] [Abstract][Full Text] [Related]
12. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
14. Metabolic fate of partially depolymerized shark chondroitin sulfate in man.
Ronca G; Conte A
Int J Clin Pharmacol Res; 1993; 13 Suppl():27-34. PubMed ID: 7995679
[TBL] [Abstract][Full Text] [Related]
15. Metabolic fate of exogenous chondroitin sulfate in the experimental animal.
Palmieri L; Conte A; Giovannini L; Lualdi P; Ronca G
Arzneimittelforschung; 1990 Mar; 40(3):319-23. PubMed ID: 2112001
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and biochemical/physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation.
Lamari FN; Theocharis AD; Asimakopoulou AP; Malavaki CJ; Karamanos NK
Biomed Chromatogr; 2006; 20(6-7):539-50. PubMed ID: 16779785
[TBL] [Abstract][Full Text] [Related]
17. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of 500 mg glucosamine sulfate in Thai healthy volunteers.
Akarasereenont P; Chatsiricharoenkul S; Pongnarin P; Sathirakul K; Kongpatanakul S
J Med Assoc Thai; 2009 Sep; 92(9):1234-9. PubMed ID: 19772185
[TBL] [Abstract][Full Text] [Related]
19. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
20. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
